Business Description
![TransMedics Group Inc TransMedics Group Inc logo](https://static.gurufocus.com/logos/0C0000BM53.png?14)
TransMedics Group Inc
NAICS : 334510
SIC : 3845
ISIN : US89377M1099
Description
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.68 | |||||
Equity-to-Asset | 0.22 | |||||
Debt-to-Equity | 3.24 | |||||
Debt-to-EBITDA | 40.21 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 5.31 | |||||
Beneish M-Score | 0.08 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 92.7 | |||||
3-Year EBITDA Growth Rate | 36.8 | |||||
3-Year EPS without NRI Growth Rate | 12.4 | |||||
3-Year FCF Growth Rate | -68.1 | |||||
3-Year Book Growth Rate | 3.2 | |||||
Future 3-5Y Total Revenue Growth Rate | 38.58 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 43.05 | |||||
9-Day RSI | 47.52 | |||||
14-Day RSI | 50.13 | |||||
6-1 Month Momentum % | 67.33 | |||||
12-1 Month Momentum % | 58.2 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 9.72 | |||||
Quick Ratio | 8.76 | |||||
Cash Ratio | 6.97 | |||||
Days Inventory | 122.06 | |||||
Days Sales Outstanding | 71.87 | |||||
Days Payable | 30.17 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -6.3 | |||||
Shareholder Yield % | -9.44 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 62.4 | |||||
Operating Margin % | -4.79 | |||||
Net Margin % | -3.43 | |||||
FCF Margin % | -77.5 | |||||
ROE % | -6.7 | |||||
ROA % | -1.65 | |||||
ROIC % | -6.56 | |||||
ROC (Joel Greenblatt) % | 0.92 | |||||
ROCE % | 0.29 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Forward PE Ratio | 4811.96 | |||||
PS Ratio | 16.02 | |||||
PB Ratio | 28.97 | |||||
Price-to-Tangible-Book | 31.79 | |||||
EV-to-EBIT | 3023.82 | |||||
EV-to-EBITDA | 387.49 | |||||
EV-to-Revenue | 16.75 | |||||
EV-to-Forward-Revenue | 12.12 | |||||
EV-to-FCF | -21.62 | |||||
Earnings Yield (Greenblatt) % | 0.03 | |||||
FCF Yield % | -4.97 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:TMDX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
TransMedics Group Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 296.919 | ||
EPS (TTM) ($) | -0.34 | ||
Beta | 2 | ||
Volatility % | 126.19 | ||
14-Day RSI | 50.13 | ||
14-Day ATR ($) | 6.721805 | ||
20-Day SMA ($) | 147.9765 | ||
12-1 Month Momentum % | 58.2 | ||
52-Week Range ($) | 36.4201 - 156.05 | ||
Shares Outstanding (Mil) | 32.94 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
TransMedics Group Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
TransMedics Group Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
TransMedics Group Inc Frequently Asked Questions
What is TransMedics Group Inc(TMDX)'s stock price today?
The current price of TMDX is $140.49. The 52 week high of TMDX is $156.05 and 52 week low is $36.42.
When is next earnings date of TransMedics Group Inc(TMDX)?
The next earnings date of TransMedics Group Inc(TMDX) is 2024-07-31.
Does TransMedics Group Inc(TMDX) pay dividends? If so, how much?
TransMedics Group Inc(TMDX) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |